4
Changes in Ownership
Grace Therapeutics, Inc. Filed Acc 0001140361-26-035316
Options or other derivatives
- Principal Financial Officer acquired 33,660 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
DelAversano Robert J · Principal Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-28 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +33,660 | 33,660 | D |
Loading xslF345X06/form4.xml…